Opportunistic infections with non-tuberculous mycobacteria such as Mycobacterium avium are receiving renewed attention because of increased incidence and difficulties in treatment. As for other mycobacterial infections, a still poorly understood collaboration of different immune effector mechanisms is required to confer protective immunity. Here we have characterized the interplay of innate and adaptive immune effector mechanisms contributing to containment in a mouse infection model using virulent M. avium strain 104 in C57BL/6 mice. M. avium caused chronic infection in mice, as shown by sustained organ bacterial load. In the liver, bacteria were contained in granuloma-like structures that could be defined morphologically by expression of the antibacterial innate effector protein Lipocalin 2 in the adjoining hepatocytes and infiltrating neutrophils, possibly contributing to containment. Circulatory antimycobacterial antibodies steadily increased throughout infection and were primarily of the IgM isotype. Highest levels of interferon-c were found in infected liver, spleen and serum of mice approximately 2 weeks post infection and coincided with a halt in organ bacterial growth. In contrast, expression of tumour necrosis factor was surprisingly low in spleen compared with liver. We did not detect interleukin-17 in infected organs or M. avium-specific T helper 17 cells, suggesting a minor role for T helper 17 cells in this model. A transient and relative decrease in regulatory T cell numbers was seen in spleens. This detailed characterization of M. avium infection in C57BL/6 mice may provide a basis for future studies aimed at gaining better insight into mechanisms leading to containment of infections with non-tuberculous mycobacteria.
Introduction
Non-tuberculous mycobacteria are widespread in the environment and their pathogenicity is receiving increased attention. Members of the most common subgroup, Mycobacterium avium complex, cause disease in immunocompromised patients and individuals with predisposing lung abnormalities, but only occasionally in the healthy population (reviewed in refs [1] [2] [3] . Previous lung infections such as tuberculosis and inflammatory disorders with pulmonary manifestations such as cystic fibrosis and rheumatoid arthritis can predispose a person to M. avium complex disease, in particular if patients are on immunosuppressive medications like anti-tumour necrosis factor (TNF) therapy. 4, 5 Inhalation of M. avium manifests as pulmonary disease whereas gastrointestinal involvement results from swallowing the bacteria. The infection can subsequently lead to disseminated disease in HIV-infected 
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patients not on anti-retroviral therapy. [6] [7] [8] In addition, lymphadenitis is observed in children without any underlying immunodeficiency. 9, 10 Today there are no vaccines to M. avium complex diseases, and recommended treatment regimens are lengthy, expensive and frequently show treatment failure or poor outcomes. 11, 12 To discover new therapeutic targets and for rational vaccine design we need to improve our understanding of the molecular and cellular host defence mechanisms providing protective immunity towards non-tuberculous mycobacteria.
Like the more virulent Mycobacterium tuberculosis, M. avium exploits macrophages as its primary host cell and causes chronic infections in mice with development of tissue granulomas. 13 Studies in mouse models have confirmed the role of central defence mechanisms shared with other intracellular pathogens, but also found aspects that seem to be divergent for M. avium, such as resistance to nitric oxide-mediated killing. 14, 15 Further complicating research is the fact that virulence and host responses to M. avium seem to be greatly influenced by the mycobacterial strain and morphotype, the mouse strain, and the route of infection (reviewed in refs 16, 17) .
Innate immune responses are important for bacterial destruction, but the chronic nature and the high incidence of both M. tuberculosis and M. avium infections in patients with AIDS who have low levels of CD4 + T cells points to the importance of adaptive immune effectors. A central step in the response to M. avium is the activation of CD4 + T helper 1 (Th1) cells producing effector cytokines such as interferon-c (IFN-c) and TNF. 18 Genetic susceptibility studies in humans have further revealed that defects in interleukin-12 (IL-12), 19 IFN-c 20 or, more recently, interferon regulatory factor-8 21 increase the risk for disseminated non-tuberculous mycobacterial disease in humans (overview in ref. 1) . Inflammatory cytokines influence the outcome of mycobacterial infection by affecting the macrophage bactericidal capacity (IFN-c, TNF), granuloma formation and maintenance (TNF, IL-1), activation of Th1 responses (IL-12), recruitment of effector cells (IL-8), increased (IL-6) and decreased (IL-10) effector responses in target T cells and macrophages (reviewed in refs 17,22,23) . In addition, a range of antibacterial proteins like lipocalin 2 (Lcn2), secretory leucocyte protease inhibitor (SLPI) and cathelicidins are induced in response to infection that will affect mycobacterial survival. [24] [25] [26] [27] For M. tuberculosis infections there is increasing evidence that successful mycobacterial immunity in addition to Th1 cells involves engagement of other T cell subsets 28 and B cells. 29 B cells may be involved in successful long-term control of mycobacterial infections by influencing cytokine production, bacillary containment and immunopathological progression of disease (reviewed in refs 29, 30 The Th17 cells  constitute a strongly pro-inflammatory subset of effector T  cells producing cytokines such as IL-17, IL-21 and IL-22 , and mediate neutrophil recruitment to the site of inflammation, 35 whereas Treg cells are potent regulators of the adaptive immune response, suppressing T cell proliferation and cytokine production. 36 We here characterize in detail the pathogenesis and the host's immune effector response mechanisms in C57BL/6 mice with M. avium 104, a virulent strain originally isolated from an AIDS patient 37 that is fully sequenced 38 and transformable. The strain was chosen as it has been described as of intermediate virulence, establishing chronic infection in C57BL/6 mice, and discussed as suitable for testing the effectiveness of vaccine candidates. 39 The intraperitoneal route of infection resulted in a fast systemic spread of the pathogen and reproducible chronic and nonresolving infection in visceral organs with bacteria contained in granulomatous structures. Our results extend previous work by analysing inflammatory cytokine levels and the antibacterial protein Lcn2 in infected organs, as well as addressing the more recently discovered Th17 and Treg cells. These findings will therefore be valuable for understanding the biology of mycobacterial infections in general and M. avium infections in particular.
Materials and methods

Mouse infections
All protocols on animal work were approved by the Norwegian National Animal Research Authorities and were carried out in accordance with Norwegian and European regulations and guidelines. C57BL/6 mice were purchased from Taconic (Bomholt, Denmark). In vivo infection was achieved by intraperitoneal injection of log-phase mycobacteria (0Á5 9 10 7 to 5Á0 9 10 7 bacteria/mouse) in 0Á5 ml PBS. At different time-points after infection, mice were killed and spleen, liver and blood samples were collected aseptically. Groups of four or five age-matched and sex-matched mice were used for each time-point. Bacterial load was measured by plating serial dilutions of organ homogenates (spleen, liver, in some experiments lung) or heparinized blood on Middlebrook 7H10 agar plates (Difco/Becton Dickinson, Franklin Lakes, NJ).
Mycobacteria
Transformants of the virulent M. avium clone 104 expressing firefly luciferase and displaying a smooth, transparent morphotype were used in all experiments and are described elsewhere. 24 Mycobacteria were cultured in Middlebrook 
Histopathology and immunohistochemistry
Organ samples were fixed in buffered formalin, processed through standard dehydration, clearing and placed in paraffin overnight, cut in 5-lm thick sections and stained with two histochemical stains: haematoxylin & eosin, which is a general tissue stain, and Ziehl-Neelsen stain to detect acid-fast bacilli using methylene blue as counterstain. For immunostaining, sections were deparaffinized and subject to antigen retrieval at pH 6, blocked and incubated overnight at 4°(TNF) or for 1 hr at room temperature (lipocalin 2; Lcn2) with antibodies against TNF (ab34674, 1 : 100; Abcam, Cambridge, UK) or Lcn2 (polyclonal rabbit anti-mouse Lcn2 antibody 807). 40 This was followed by incubation with biotinylated secondary antibody (goat-anti-rabbit, 1 : 200; Dako, Glostrup, Denmark) and LSAB2 streptavidin-horseradish peroxidase (Dako). Sections were resolved using the EnVision DAB dectection system (Dako).
Cytokine detection by ELISA and quantitative real-time PCR
Cytokines levels were quantified by ELISA analysis from plasma samples as well as homogenized liver and spleen tissue using ELISA kits for mouse IFN-c ('Femto HS' Ready-SET-Go!; eBioscience, San Diego, CA) and TNF (TNF-a DuoSet; R&D Systems, Minneapolis, MN). For quantitative real-time PCR analysis, tissue samples from spleen and liver were homogenized by bead-beating with a FastPrep-24 instrument (MP Biomedicals, Solon, OH). Total RNA was isolated in an automated protocol using the RNeasy Mini Kit with DNase I digestion on a QIAcube instrument (all Qiagen, Hilden, Germany). After cDNA synthesis (High-Capacity Reverse Transcription Kit, Applied Biosystems, Foster City, CA), quantitative realtime PCR was performed on a StepOnePlus pPCR System using TaqMan Fast Advanced Master Mix and TaqMan Gene Expression Assays (all Applied Biosystems). Tissue samples from all mice in a group (n = 4 or n = 5) were pooled and run in duplicates. Gene expression was normalized to glyceraldehyde 3-phosphate dehydrogenase and b-actin as endogenous controls and relative quantification values to gene expression in uninfected mice were calculated with STEPONE SOFTWARE 2.1 (Applied Biosystems).
Mycobacteria-specific antibody responses
Specific antibody responses to M. avium were analysed in mouse serum samples by ELISA. Briefly, 96-well half-area ELISA plates (Corning, Incorporated Life Sciences, NY) were coated with culture filtrate from M. avium grown for approximately 10 days in Sauton's medium and filtered through a 0Á22-lm sterile filter. Samples and standards were diluted in reagent buffer (0Á1% Casein/0Á1% BSA in PBS) and incubated at room temperature for 2 hr. Serial dilutions of Anti-M. avium complex Ab18104 (IgG1, QEDBioscience Inc., San Diego, CA) starting at 100 ng/ml was used as standard. Total mycobacteria-specific antibodies were detected by horseradish peroxidaseconjugated rabbit anti-mouse antibodies (Dako) diluted 1 : 2000 (30 min at room temperature), followed by tetramethylbenzidine Microwell Peroxidase Substrate System (KPL, Gaithersburg, MD). For determination of isotype distribution, mycobacteria-specific antibodies were detected by rabbit anti-mouse subclass-specific antibodies (Zymed, San Francisco, CA; 1 hr room temperature) followed by horseradish peroxidase-conjugated goat antirabbit antibodies (Dako) diluted 1 : 4000, and tetramethylbenzidine substrate. Absorbance was read at 450 nm subtracting 570 nm using a Wallac Victor Multilabel reader (PerkinElmer, Waltham, MA).
Isolation of splenocytes and flow cytometric characterization
After preparing single-cell suspensions and lysis of red blood cells (red blood cell lysis buffer, eBioscience), splenocytes were characterized for the expression of cell surface antigens by staining with monoclonal antibodies to CD4, CD8, CD19, CD25, CD44, CD45RB, CD69, T cell receptor a, T cell receptor cd, CD11b, Ly-6G and F4/80 (eBioscience and BioLegend, San Diego, CA). Treg cells were detected by intracellular FoxP3 staining using a FoxP3 Fix/Perm kit (BioLegend) and FoxP3 antibody (clone 150D, BioLegend). Flow cytometric analysis was performed on a BD LSR II flow-cytometer (BD Biosciences). Absolute cell numbers of B and T cells per spleen were calculated from the relative frequencies using flow cytometric phenotyping and the total number of cells counted after isolation from the organ. Data were analysed using FLOWJO software (Tree Star, Ashland, OR); statistical analysis was performed using GRAPHPAD PRISM (GraphPad Software, Inc., San Diego, CA).
Mycobacteria-specific T cell cytokine production
Isolated splenocytes were resuspended in RPMI-1640 (Sigma)/10% fetal calf serum/10 mM HEPES/50 lM 2-mercaptoethanol and 5 9 10 5 cells/well were seeded in 96-well tissue culture plates. Cells were incubated with M. avium overnight at a cell ratio of 1 : 1, Brefeldin A (eBioscience) was added for the last 4 hr. Unstimulated cells and cells stimulated with the T cell mitogen concanavalin A (2Á5 lg/ml, Sigma) were used as controls. Cells were resuspended, surface-stained for CD4 and CD8 and 
Results
M. avium 104 causes chronic disseminated infection in C57BL/6 mice and is contained in non-necrotic granuloma-like structures in spleen and liver C57BL/6 mice were infected intraperitoneally with the virulent M. avium strain 104 resulting in a rapid, systemic infection. Mycobacteria were found in the spleen, liver and blood 1 day after infection (Fig. 1a) . Whereas the bacteria were gradually cleared from the blood, organ bacterial load increased for the first 10-20 days and then remained surprisingly constant in spleen, liver and lungs throughout the course of experiments (Fig. 1a,b ) and was therefore classified as a chronic disseminated infection. In accordance with observations in mice 41, 42 and humans, 43 the developing inflammatory response was reflected in splenomegaly peaking 20-30 days post infection with a sixfold to 10-fold increase in spleen weight (Fig. 1c) . Splenomegaly seemed to be partly caused by growth or recruitment of cells as a twofold to threefold increase in total spleen cell numbers was found (Fig. 1d ). Mice appeared surprisingly healthy throughout infection and showed no clinical signs of disease such as fever, weight loss, loss of appetite, ruffled fur or discomfort. We have followed mice for 25 weeks post infection without animals dying or fully clearing the infection (not shown).
A hallmark of infection with pathogenic mycobacteria is the formation of tissue granulomas around infected macrophages. 44 Granulomatous structures appeared in spleen and liver of M. avium-infected mice about 10 days post infection (Fig. 1e) . In the spleen, granulomas evolved from ill-defined epitheloid structures with scattered multinucleated giant cells in the intervening red pulp (day 11), to more defined granulomas with only a few multinucleated giant cells (days 21 and 41). At day 98 the granulomas appeared to be less cellular, containing scattered elongated nuclei, and the number of multinucleated giant cells was markedly reduced. The fibrous central core of these late granulomas showed no sign of necrosis as observed in the study with M. avium strain 724R by Kondratieva et al. 45 Granulomas appeared mainly in the red pulp, and to a lesser extent in the follicles, either piercing the periphery or appearing inside. The number of liver granulomas increased along with the number of organ colony-forming units (Fig. 1f) . From acid-fast staining we found mycobacteria in the liver and spleen almost exclusively localized to granulomas (Fig. 1g ).
M. avium induces stronger inflammatory responses in liver than in spleen
Inflammatory proteins were in general more strongly induced in the liver than in the spleen, as seen for IL-1b and the NOD-like receptor protein 3 (NLRP3) inflammasome/caspase-1 involved in processing of IL-1b (Fig. 2a) . Inducible nitric oxide synthase (iNOS; NOS2) was increasingly up-regulated in both spleen and liver (Fig. 2a) . Both IFN-c mRNA and protein peaked 12 days post infection in all studied organs followed by a decrease in plasma and the spleen, whereas liver levels were sustained (Fig. 2a-c) . Interleukin-6 mRNA, important for T cell differentiation and early IFN-c, appeared after IFN-c induction (Fig. 2a) . Surprisingly, TNF and IL-12 mRNA were only weakly induced in the spleen whereas a gradual increase over time was observed in the liver (Fig. 2a,b) . We were unable to detect TNF protein in spleen and plasma while liver TNF was elevated throughout infection (Fig. 2c) . Immunohistochemical staining revealed initial TNF production mostly in hepatocytes, although over time epitheloid, cytoplasm-rich cells (presumably macrophages) in liver granulomas stained increasingly positive for TNF (Fig. 2d) . In contrast, only scattered epithelial cells made TNF in the spleen, until increased expression was seen in ill-defined granulomas at day 98 (Fig. 2d) . Uninfected mice displayed no distinct staining of TNF in the spleen and only in a few liver cells (see Supplementary material, Fig. S1A) .
We have previously shown that the inflammatory and bacteriostatic protein Lcn2 prevents the growth of extracellular M. avium.
24 Lcn2 protein and mRNA were strongly induced and sustained in spleen, liver and serum over the course of infection (Fig. 2a-c) . Interestingly, immunohistochemical staining for Lcn2 40 revealed not only the presence of infiltrating neutrophils but also how inflammatory responses were first initiated in hepatocytes closely adjoining the granulomas (as indicated by the arrows in Fig. 2d ) before progressing throughout the infected liver at later stages of infection. Actually, liver granulomas were easily identified as clusters of lymphocytes and mononuclear cells that do not make Lcn2 (Fig 2d and refs 40,46 ). In the spleen neutrophils were the most prominent Lcn2 producers, but the potent induction of Lcn2 mRNA (Fig. 2a,b) points to other cellular sources as well, because new synthesis is not induced in neutrophils. 47 Only scattered neutrophils stained positive for Lcn2 in uninfected mice (Fig. S1B) . mechanisms at a cellular level we characterized the composition of spleen immune cell subsets at different times post infection. An example of flow cytometric analysis and gating of splenocytes is shown in Fig. 3(a) . CD19 + B cells and CD3 + T cells constituted the majority of splenocytes. B cell numbers increased a few days after infection followed by an increase in T cell numbers around day 8 (Fig. 3b) , and no loss of T cells was evident even at late time-points. T cell subtyping further revealed approximately 70% CD4 + T cells and 25% CD8 + T cells in the total CD3 + T cell population at the initiation of infection, followed by a significant increase up to 38% CD8 + T cells 20-30 days post infection (Fig. 3c, left  graph) . Of the CD8 + T cells > 90% expressed the T cell receptor ab at the beginning of infection, increasing to 95% at day 30. In parallel we observed a decrease in relative T cell receptor cd expression (Fig. 3c, second graph) . The fraction of naive T cells expressing an early activated phenotype (CD44 ++ CD69 + ) increased first for CD4 + T cells (from around day 10) and later for CD8 + T cells (Fig. 3c, third graph) . Growing numbers of memory-type CD4 + and CD8 + T cells (CD44 ++ CD45RB low ) were detected from day 17 (Fig. 3c, right) , so with delayed kinetics compared with activated T cells (CD44 ++ CD69 + , Fig. 3c, third graph) . Relative frequencies and absolute numbers of B cells and different T cell subsets in the spleen can be found in Supplementary material, Table S1 .
Mycobacterium-specific antibody production increases progressively during infection; CD4 + and CD8 + effector T cell responses coincide with reduced organ bacterial load M.avium-specific antibodies were present in serum around day 10 ( Fig. 3d, left graph) , corresponding to the time when bacteria started to clear from the blood (as shown in Fig. 1a , right panel), and increasing concentrations of specific antibodies were observed over the 100-day experimental period (Fig. 3d) . IgM was most abundant throughout infection and the isotype switch to IgG at later stages of infection (from day 42) was predominated by IgG2b antibodies followed by IgG2a and IgG3 (Fig. 3d, right graph) . Successful adaptive immunity towards M. avium depends on activation of mycobacteria-specific T cells producing effector cytokines. 18 The frequency of CD4 + and CD8 + T cells spontaneously producing IFN-c was low in M. avium-infected spleens but could be increased by in vitro re-challenge with M. avium or the T cellstimulating lectin concanavalin A (Fig. 3e, 23 days post  infection) . A subpopulation of the M. avium-specific, IFN-c-producing CD4 + effector T cells also produced TNF (about 10%, 1% of total CD4 + T cells), but no sole TNF-producing CD4 + T cells were found and CD8 + T cells did not produce TNF in response to M. avium (Fig. 3e ). An average of 0Á63% of non-T cells in the spleen (CD4 -and CD8 increased research interest. 36, [48] [49] [50] While different nontuberculous mycobacteria were recently described to induce Th17 responses in humans 34 as well as bacillus Calmette-Gu erin infection in IFN-c-deficient mice, 49 Th17 and Treg cells have not been addressed in mouse M. avium infections.
We analysed Th17 cell frequencies by intracellular IL-17-staining of splenocytes at day 22 (not shown) and day 42 (Fig. 4a) post-M. avium infection. A tiny population of Th17 cells emerged when splenocytes were re-challenged with the positive control concanavalin A, but we did not detect IL-17-producing cells in response to M. avium. Moreover, no IL-17 messenger RNA could be measured in liver or spleen 5, 12 or 42 days post M. avium infection (not shown). The Treg cells were characterized as CD4 + T cells co-expressing CD25 and the transcription factor FoxP3 (CD4 + CD25 + FoxP3 + , Fig. 4b ). We observed a substantial relative decrease in splenic FoxP3
+ Treg cell numbers between days 10 and 20 post M. avium infection (Fig. 4c) coinciding with the increase in CD44 + CD69 + activated T cells (Fig. 3c) , although no significant changes in total numbers of Treg cells were seen (Fig. 4d ).
Discussion
We still have an incomplete understanding of successful anti-mycobacterial immunity and mouse infection models are valuable to reveal cellular and molecular defence mechanisms relevant for anti-mycobacterial therapy. A central challenge in studying immune functions towards non-tuberculous mycobacteria such as M. avium is the huge variety of M. avium strains and their diversity. Mycobacterium avium isolates range from non-virulent with clearance of the infection 39, 51 to highly virulent strains causing uncontrolled growth of the pathogen, T cell loss and induction of necrosis in granulomatous structures of infected mice. [52] [53] [54] In this study we have characterized the complex interplay of immune effector mechanisms in C57BL/6 mice during infection with the clinical isolate M. avium 104. The intraperitoneal route of infection was chosen as it reproducibly results in a rapid, systemic infection 24 that is sustained without resolution, similar to intravenous administration as shown by Saunders et al. 39 We confirm the results of Saunders et al. that M. avium 104 established chronic disseminated infection in tissues with inflammatory cell recruitment, granuloma formation as well as strong T cell responses, 39 and we extend the findings by characterizing additional cellular and molecular host defence mechanisms that may contribute to successful control of M. avium infection.
Expression of the innate immune effector protein Lcn2 dramatically increased both in serum and organs of infected mice. In the liver, bacteria were contained in granuloma-like structures that could be defined morphologically by expression of Lcn2 in adjoining hepatocytes and infiltrating neutrophils. Rodrigues et al. 55 also saw some Lcn2 induction around mycobacterium-positive liver granulomas in a study where the authors suggest a possible role for Lcn2 in mycobacterium-induced anaemia. Lcn2 is also induced in mouse bone-marrow-derived macrophages, 24,40 but we could not detect Lcn2-producing macrophages or multinucleated giant cells in tissue granulomas. Takeda's group has demonstrated that Lcn2 is induced in alveolar macrophages and epithelial cells, and that Lcn2-deficient mice are susceptible to intratracheal infection with M. tuberculosis. 25 We have previously shown that Lcn2 prevents the growth only of extracellular M. avium, 24 but it is not possible to say if the massive induction of Lcn2 in hepatocytes along with release of pre-made Lcn2 from neutrophils could contribute to containment of the mycobacteria to granulomas. 47, 56, 57 Like Lcn2, humoral immunity may also contribute to limit extracellular growth and spread of the mycobacteria. 29, 30 Studies in mice and cynomolgus macaques infected with M. tuberculosis have demonstrated the presence in granulomas of activated B cells producing mycobacterium-specific antibodies, 58, 59 and B cell deficient mice displayed exacerbated immunopathology and elevated lung bacterial burden compared with wild-types. 58 By comparing M. avium infections in BALB/c and SCID mice Fattorini et al. 31 have likewise suggested that both T and B cells are required to control M. avium infection. This is in line with our observations of elevated antibody production as well as IFN-c + effector T cells throughout infection. A strong and early increase in B cell numbers and production of M. avium-specific antibodies from day 10 coincided with the early clearance of extracellular bacteria from the blood (day [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The isotype dominance of IgM followed by IgG2b was slightly different from the IgG2a dominance described for M. tuberculosis-infected mice 60 and could reflect an abundance of lipids and sugars shed from the mycobacterial envelope promoting T cell independent IgM responses, but also the antigen coat used in the immunoassay (M. avium culture filtrate).
Through a series of studies by Bermudez, Appelberg, Ehlers and others, the individual roles of various inflammatory cytokines in M. avium-infected animals have been described. 13, 17, 18, [61] [62] [63] [64] As expected, the key effector cytokine IFN-c mRNA and protein was sustained in infected organs throughout infection. TNF is, along with IFN-c and IL-1, suggested to be important for granuloma development and containment of infection with M. tuberculosis and M. avium, 13, 61, 65 although the importance of TNF in mouse M. avium infection is not fully clarified. Ehlers et al. 62 found TNF receptor knock-out mice to be more susceptible to M. avium strain TMC724 infection as the result of deficiencies in granuloma formation, whereas Silva et al. 66 claimed a minor role for TNF especially with decreased virulence of the M. avium strain. In concordance with Appelberg et al. 18 we found low levels of TNF in M. avium-infected spleens. TNF mRNA was low and protein was undetectable (< 0Á5 ng/g) in spleen homogenates, although we did observe some induction of TNF in inflamed areas of the spleen by immunohistochemistry but a fraction of isolated splenic CD4 + T cells produced TNF in addition to IFN-c. This finding indicates that mouse M. avium strain 104 infection results in induction of polyfunctional CD4 + T cell responses with combined simultaneous production of several effector cytokines. The quality of CD4 + and CD8 + T cell responses, as measured by simultaneous production of IFN-c, TNF and IL-2 from polyfunctional T cells, receives increased interest as it has been shown to correlate with protective longterm immunity against M. tuberculosis. 67 But although polyfunctional T cells were found to be important in vaccine-induced protection against pathogens such as Leishmania major, 68 polyfunctionality of the T cell responses alone seems not to be sufficient to predict protective vaccine immunity against M. tuberculosis. 69, 70 However, the low and local production of TNF may be sufficient, as formation of granuloma structures with containment of infection in the spleen was seen. Since bacterial containment in granuloma-like structure and control of infection was evident both in spleen and liver, our results suggest that TNF has a potent local effect in the spleen. It has been reported that less virulent mycobacteria are more sensitive to TNF. 71 We found adequate TNF responses in the liver as well as in isolated human or mouse macrophages (data not shown), so given the high influx of neutrophils and macrophages to the spleen from 1 week post infection we would have expected a higher production of inflammatory cytokines. Concomitant induction of anti-inflammatory IL-10 has previously been found to negatively influence the secretion of TNF and IFN-c in response to mycobacterial infection compared with other Gram-positive or Gram-negative microbes in human peripheral blood monocytes. 34 However, we did not observe high inductions of IL-10 in the spleen and currently cannot explain the low levels of TNF and other inflammatory proteins induced by M. avium 104.
Different T cell subsets produce IL-17. The most prominent source is CD4 + Th17 cells that seem more important in memory responses and vaccine-induced immunity than in control of primary M. tuberculosis. 49, 72, 73 Interleukin-17-producing cd T cells are also found in M. tuberculosis-infected tissue, although their function is rarely investigated. 74, 75 We did not detect significant IL-17A expression in liver and spleen tissue, nor did we find M. avium-specific Th17 or increased numbers of cd T cells in spleens of infected mice. The absence of Th17 cell differentiation might possibly be a result of raised levels of IFN-c, which has also been implicated as a negative regulator of antigen-specific Th17 development during primary bacillus Calmette-Gu erin infection. 76 The decrease in relative cd T cell frequency might be explained by expansion of activated ab T cells as previously described in mouse M. tuberculosis infections. Little is known about the function of Treg cells in infections with M. avium, but HIV-infected patients with mycobacterial immune restoration disease seem to develop a strong Th1 response with functionally comprised Treg cells. 33 We observed no change in absolute splenic Treg cell numbers during the first 30 days of infection. This is in contrast to M. tuberculosis-infected mice, where the fraction of Treg cells was constant and so total numbers seemed to expand along with T cell numbers in affected organs. 77 However, we saw a relative decrease in Treg cell numbers between days 10 and 20 after infection coinciding with an increase in CD44 + CD69 + activated T cells and a strong pro-inflammatory cytokine environment in infected tissues. This phase favouring immune activation and inflammation rather than suppression might be important to successfully achieve containment of infection. Further studies of the function of Treg cells in non-tuberculous mycobacteria infections are ongoing.
The aim of this study was to provide a detailed characterization of the immune effector mechanism during M. avium strain 104 infection in C57BL/6 mice. The 104 strain was the first M. avium strain to be fully sequenced 38 and is suggested as a reference strain for testing the effectiveness of drug or vaccine candidates. 39 We think this model is useful also for in vivo studies of host-pathogen relations in mycobacterial infections because C57BL/6 is the most common genetic background for transgenic mice. Our study describes new aspects of innate, humoral and adaptive immune processes previously not addressed in the host's defence during long-term infections with M. avium. Together with studies revealing general mechanisms involved in mycobacterial infection 42 our findings may contribute to a better understanding of M. avium infections in particular and mycobacterial infections in general, and help in providing a solid basis for rational design of new vaccine and treatment strategies.
